Table 2 Adverse events of special interest and hematological toxicities.
Toxicities, n (%) | All patients (n = 12) | Toxicities, n (%) | All patients (n = 12) |
|---|---|---|---|
Cytokine release syndrome | 3. Febrile neutropenia | ||
Grade III | 2 (17%) | Grade III/IV | 0 (0%) |
Grade II | 1 (8%) | Grade II | 10 (83%) |
All Grades | 10 (83.3%) | All Grades | 10 (83%) |
ICANS | 4. Anemia | ||
Grade III/IV | 0(0%) | Grade III/IV | 07 (58%) |
Grade II | 1 (8%) | Grade II | 03 (25%) |
All Grades | 1(8%) | All Grades | 12 (100%) |
Hematological toxicities | 5. Platelet count decreased | ||
1. Cytopenia | Grade III/IV | 06 (50%) | |
Grade III/IV | 12 (100%) | All Grades | 10 (83%) |
All Grades | 12 (100%) | 6. Leukopenia | |
2. Neutropenia | Grade III/IV | 09 (75%) | |
Grade III/IV | 12 (100%) | All Grades | 12 (100%) |
